Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-147-2 | CAS number: 15096-41-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 April 2017 - 04 October 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Tetrachloro-μ-hydroxy(μ-methacrylato-O:O')dichromium
- EC Number:
- 239-147-2
- EC Name:
- Tetrachloro-μ-hydroxy(μ-methacrylato-O:O')dichromium
- Cas Number:
- 15096-41-0
- Molecular formula:
- C10H23Cl4Cr2O5
- IUPAC Name:
- complexation reaction product of Tetrachloro-μ-hydroxy(μ-methacrylato-O:O')dichromium, isopropylalcohol and water
- Test material form:
- liquid
Constituent 1
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- The reconstructed human epidermis model in vitro method is an accepted in vitro method to replace animal testing. The human skin RHE™ model closely mimics the biochemical and physiological properties of the upper parts of the human skin, i.e the epidermis, and has been validated by the ECVAM in 2008.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: The SkinEthic™ RHE-model RHE/S/17, Episkin/SkinEthic Laboratories, Lyon, France.
- Tissue batch number: 17-RHE-086
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation: 37 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: gently rinsing with a minimum volume of 25 mL DPBS using a pipette. Excess DPBS was removed by gently shaking the tissue inserts and blotting the bottom of the tissue inserts with blotting paper. The inserts were placed in 6-well plates with 2 mL fresh pre-warmed (room temperature) growth medium.
- Observable damage in the tissue due to washing: No
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3 h
- Spectrophotometer: Spectrophotometer (ELx800, BioTek Instruments GmbH, Bad Friedrichshall, Germany)
- Wavelength: 570 nm
NUMBER OF REPLICATE TISSUES: 3
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
- killed tissues
- Procedure used to prepare the killed tissues: not specified
- N. of replicates : 3
- Method of calculation used: see "Any other information on materials and methods"
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be non-irritating to skin if the mean tissue viability is > 50 % after incubation period.
- The test substance is considered to be irritating to skin if the mean tissue viability is ≤ 50 % after incubation period. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 16 µL ± 0.5 µL per tissue
NEGATIVE CONTROL
- Amount applied: 16 µL ± 0.5 µL per tissue
POSITIVE CONTROL
- Amount applied: 16 µL ± 0.5 µL per tissue - Duration of treatment / exposure:
- 42 min
- Duration of post-treatment incubation (if applicable):
- 42 h
- Number of replicates:
- 3
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 76.7
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No
- Direct-MTT reduction: Yes
- Colour interference with MTT: No
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: Yes
Any other information on results incl. tables
Acceptability of the Quality Control Data of the Skin Model with Reference to Historical Batch Data:
|
Acceptance Criterion |
Result |
Negative control OD |
≥ 0.8 and ≤ 3.0 |
1.930 to 2.127 |
Acceptability of the Positive and Negative Control stated by Episkin/SkinEthic Laboratories: |
|
Acceptance Criterion |
Result |
Mean OD negative control |
≥ 1.2 |
2.019 |
Mean viability positive control |
< 40 % |
1.0 % |
SD of group-mean value |
≤ 18 % |
10.0 % (positive control) 4.9 % (negative control) |
Acceptability of the Positive and Negative Control based on Historical Data of the Testing Laboratory: |
|
Acceptance Criterion |
Result |
Mean OD negative control |
≥ 1.463 |
2.019 |
Mean viability positive control |
≤ 2.98 % |
1.0 % |
Test Item Data Acceptance Criteria: |
|
Acceptance Criterion |
Result |
SD of group-mean value |
≤ 18 % |
7.3 % |
The study met all acceptance criteria.
The means of the negative controls and the positive control of all performed experiments in the testing laboratory are given in the following table:
Positive Control |
Negative Control |
||
Mean Viability [%] |
1.45 |
Mean Absorption [OD570] |
2.015 |
Standard Deviation |
0.51 |
Standard Deviation |
0.276 |
The results obtained after treatment of the reconstructed human epidermis model with the test substance are given in the following table:
Group |
Tissue 1 |
Tissue 2 |
Tissue 3 |
Mean |
SD |
||||
OD |
Viability (%) |
OD |
Viability (%) |
OD |
Viability (%) |
OD |
Viability (%) |
Viability (%) |
|
Negative Control |
2.127 |
105.3 |
1.930 |
95.6 |
2.001 |
99.1 |
2.019 |
100.0 |
4.9 |
Positive Control |
0.021 |
1.0 |
0.019 |
0.9 |
0.022 |
1.1 |
0.021 |
1.0 |
10.0 |
Test Substance |
1.510* |
71.0 |
1.587* |
82.2 |
1.540* |
77.0 |
1.546 |
76.7 |
7.3 |
* corrected optical density after true metabolic conversion
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an in vitro skin irritation assay (RhE) according to OECD Guideline 439, a cell viaability of 76.7 % was determined. Thus the test substance is not considered as skin irritant.
- Executive summary:
In an in vitro skin irritation assay (RhE) according to OECD Guideline 439, the skin irritating potential of the test item was investigated. The test item was applied topically to a human reconstructed skin model followed by determination of the cell viability. Cell viability was determined by enzymatic conversion of vital dye MTT into a blue formazan salt and measurement of the formazan salt after extraction from tissues. The percent reduction of cell viability in comparison to untreated negative controls was used to predict the skin irritation potential. Triplicates of the human skin RHE-model were treated with the test item, the negative or the positive control for 42 minutes (± 1 minute). 16 µL of either test item, the negative control (DPBS-buffer) or the positive control (5 % aqueous solution of sodium dodecyl sulfate) were applied to the tissues. The test item has the ability to directly reduce MTT. To evaluate the extent of non-specific interaction, three killed tissues were treated with the test item and three killed untreated tissues were used as negative control. The treatment and MTT assay of the killed tissues was similar to the handling of the living tissues. The obtained OD for a non-specific reduction was subtracted from OD-values obtained after treatment of living tissues with the test item to calculate the cell viability. All acceptability criteria after treatment with the negative control (DPBS-buffer) and the positive control (5 % aqueous solution of sodium dodecyl sulfate) were met. Following treatment with the test substance, the tissue viability was 76.7 % and, thus, higher than 50 %, i.e. according to OECD 439 the test item is considered as non-irritant to skin (UN GHS: No Category). Under the conditions of the present study, the test substance is not considered to possess an irritant potential to skin (UN GHS: No Category).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.